OTCMKTS:PCSA - Processa Pharmaceuticals Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
$3.00 +0.01 (+0.33 %)
(As of 08/17/2018 04:00 PM ET)
Previous Close$3.00
Today's Range$2.65 - $3.00
52-Week Range$2.30 - $5.1250
Volume3,030 shs
Average Volume881 shs
Market Capitalization$105.11 million
P/E RatioN/A
Dividend YieldN/A
Processa Pharmaceuticals, Inc., a pharmaceutical company, engages in the clinical development of drug products for the unmet medical needs. Its lead product candidate is PCS-499, an oral tablet for the treatment of necrobiosis lipoidica and radiation-induced fibrosis in head and neck cancer patients. The company is based in Hanover, Maryland.

Receive PCSA News and Ratings via Email

Sign-up to receive the latest news and ratings for PCSA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Stock Exchange OTCMKTS
Industry Pharmaceutical preparations


Debt-to-Equity Ratio0.38
Current Ratio0.65
Quick Ratio0.65


Trailing P/E RatioN/A
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book Value$0.01 per share
Price / Book300.00


EPS (Most Recent Fiscal Year)N/A
Net Income$-1,850,000.00
Net MarginsN/A
Return on Equity-154.60%
Return on Assets-49.56%


Outstanding Shares35,270,000
Market Cap$105.11 million

Processa Pharmaceuticals (OTCMKTS:PCSA) Frequently Asked Questions

What is Processa Pharmaceuticals' stock symbol?

Processa Pharmaceuticals trades on the OTCMKTS under the ticker symbol "PCSA."

How were Processa Pharmaceuticals' earnings last quarter?

Processa Pharmaceuticals Inc (OTCMKTS:PCSA) posted its quarterly earnings data on Monday, May, 21st. The company reported ($0.03) earnings per share (EPS) for the quarter. View Processa Pharmaceuticals' Earnings History.

When is Processa Pharmaceuticals' next earnings date?

Processa Pharmaceuticals is scheduled to release their next quarterly earnings announcement on Wednesday, October, 3rd 2018. View Earnings Estimates for Processa Pharmaceuticals.

Who are some of Processa Pharmaceuticals' key competitors?

Who are Processa Pharmaceuticals' key executives?

Processa Pharmaceuticals' management team includes the folowing people:
  • Dr. David Young, Co- Founder, Chairman, CEO & Interim CFO (Age 65)
  • Mr. Patrick Lin, Co-Founder, Chief Bus. & Strategy Officer and Internal Director (Age 53)
  • Dr. Sian E. Bigora, Co-Founder & Chief Devel. Officer (Age 58)
  • Ms. Wendy Guy, Co-Founder & Chief Admin. Officer (Age 54)
  • Dr. Maya Das M.D., J.D., VP of Clinical Research

Has Processa Pharmaceuticals been receiving favorable news coverage?

Headlines about PCSA stock have trended positive this week, according to Accern Sentiment. The research group identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real time. Accern ranks coverage of publicly-traded companies on a scale of -1 to 1, with scores nearest to one being the most favorable. Processa Pharmaceuticals earned a media and rumor sentiment score of 0.28 on Accern's scale. They also gave media coverage about the company an impact score of 47.35 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. View Recent Headlines for Processa Pharmaceuticals.

How do I buy shares of Processa Pharmaceuticals?

Shares of PCSA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is Processa Pharmaceuticals' stock price today?

One share of PCSA stock can currently be purchased for approximately $3.00.

How big of a company is Processa Pharmaceuticals?

Processa Pharmaceuticals has a market capitalization of $105.11 million. Processa Pharmaceuticals employs 13 workers across the globe.

How can I contact Processa Pharmaceuticals?

Processa Pharmaceuticals' mailing address is 7380 COCA COLA DRIVE SUITE 106, HANOVER MD, 21076. The company can be reached via phone at 443-776-3133 or via email at [email protected]

MarketBeat Community Rating for Processa Pharmaceuticals (OTCMKTS PCSA)

Community Ranking:  2.6 out of 5 (star star)
Outperform Votes:  25 (Vote Outperform)
Underperform Votes:  24 (Vote Underperform)
Total Votes:  49
MarketBeat's community ratings are surveys of what our community members think about Processa Pharmaceuticals and other stocks. Vote "Outperform" if you believe PCSA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe PCSA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 8/18/2018 by MarketBeat.com Staff

Featured Article: Google Finance Portfolio

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.